Optimizing Targeted Inhibitors of P-Glycoprotein Using Computational and Structure-Guided Approaches

Area of Science:

• Biochemistry
• Computational Chemistry
• Pharmacology

Background:

• Overexpression of P-glycoprotein (P-gp) contributes to multidrug resistance in cancer chemotherapy.
• Existing P-gp inhibitors have not achieved clinical approval, necessitating novel therapeutic strategies.

Purpose of the Study:

• To improve the characteristics of a novel P-gp inhibitor using computational approaches and structure-based design.
• To develop and validate a virtual chemical synthesis and assessment program, ChemGen, for designing P-gp inhibitors.

Main Methods:

• Utilized computational approaches and structure-based design to generate P-gp inhibitor variants.
• Employed the ChemGen program for virtual chemical synthesis and computational assessment.
• Synthesized and evaluated several inhibitor variants for efficacy in reversing multidrug resistance and biochemical inhibition mechanisms.

Main Results:

• Successfully designed and synthesized P-gp inhibitor variants with improved binding characteristics.
• Demonstrated the efficacy of these variants in reversing multidrug resistance in cell culture models.
• Validated the computational predictions of binding characteristics against experimental data.

Conclusions:

• The ChemGen program is a valuable tool for accelerating the design of novel P-gp inhibitors.
• The developed inhibitor variants show promise for combination therapy in overcoming cancer multidrug resistance.
• Computational and structure-based design approaches are effective in optimizing drug candidates targeting ABC transporters.